Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome

Table 4

Differential metabolites in the plasmas of CRC patients with QD compared with those with YD.

	VIP	mz	rt	Name	t-test	log2(QD/YD)
Upregulated	1.181	451	14.43	Diphosphate	0.001	1.935
	1.089	299	15.47	Phosphoric acid propyl ester	0.001	1.728
	1.522	258	7.43	3-Oxaoct-4-en-11-imine	0.000	1.434
	1.714	79	9.27	Urea	0.000	1.395
	1.878	181	9.64	Phosphoric acid	0.000	1.279
	1.01	137	19.63	Oleic acid	0.003	1.213
	1.2	170	6.52	Hydroxycyclohexane	0.000	1.113
	1.107	157	12.70	Pyroglutamic acid	0.001	1.045
	1.036	77	6.22	carbamate	0.003	0.999
	1.202	273	16.06	Citric acid	0.000	0.992
	1.17	248	12.07	Aminomalonic acid	0.001	0.966
	1.466	80	20.93	Arachidonic acid	0.000	0.944
	1.028	79	19.59	Linoleic acid	0.003	0.904
	1.098	133	7.73	Oxalic acid	0.001	0.888
	1.598	155	11.92	GABA	0.000	0.849
	1.665	57	27.67	Cholesterol	0.000	0.825
	1.274	370	22.69	1-Monopalmitoylglycerol	0.000	0.665
	1.203	341	19.82	Stearic acid	0.000	0.626
	1.261	155	11.58	Ethylamine	0.000	0.461
Downregulated	1.04	73	17.06	d-Glucose	0.002	−0.255
	1.759	75	17.06	Threose	0.000	−1.017
	1.561	206	17.70	β-D-Allopyranose	0.000	−1.126
	1.335	205	16.89	Glucopyranose	0.000	−1.259
	1.622	221	17.04	Mannose	0.000	−1.267
	1.924	321	16.98	d-Galactose	0.000	−1.296
	1.668	132	9.22	5-Hydroxycaproic acid	0.000	−1.482